Insights from 2024 ASCO® GI Annual Meeting


 

ASCO® GI 2024 Insights: "KEYSTEP-004 Study - Coformulated Quavonlimab and Pembro in Combination With Lenvatinib as 1L Therapy for Patients With Advanced HCC"

156 views
January 31, 2024
Comments 0
Login to view comments. Click here to Login